# To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion

> **NCT00857168** · PHASE1 · COMPLETED · sponsor: **Acrux DDS Pty Ltd** · enrollment: 36 (estimated)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** Testosterone MD-Lotion

## Key facts

- **NCT ID:** NCT00857168
- **Lead sponsor:** Acrux DDS Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-02
- **Final completion:** 2009-04
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2009-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00857168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00857168, "To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00857168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*